![Eric Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 3 $ in data 31/05/2026
Eric C.
Hsu is Senior VP-Pre-Clinical Research & Development at InMed Pharmaceuticals, Inc. since 2018.
Formerly, Dr. Hsu was VP-Scientific Affairs, Research & Operations at enGene, Inc. from 2002 to 2018.
Education includes an undergraduate degree from McGill University and a doctorate from the University of Toronto conferred in 1999.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 19/12/2025 | 2 ( 0% ) | 3 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Direttore Tecnico/Scientifico/R&S | 13/03/2018 |
| Società | Posizione | Fine |
|---|---|---|
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Direttore operativo | 01/01/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which develops non-viral gene therapies | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
